Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Best time to walk after ProGlide femoral artery closure

Official title: Optimizing Time to Ambulation After ProGlide Closure of Femoral Access: A Randomized Controlled Trial

Run by Chinese Academy of Medical Sciences, Fuwai Hospital · NCT07179536 · Data updated 2026-11-12

This trial will test different times for getting up and walking after ProGlide closure in adults having transfemoral peripheral angiography or endovascular procedures to find a timing that's safe and lets patients ambulate sooner.

More Vascular Access Complication trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment300 (estimated)
SponsorChinese Academy of Medical Sciences, Fuwai Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedMarch 30, 2026
Study endsMarch 30, 2026
Registry record updatedJanuary 23, 2026
Trial IDNCT07179536 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults scheduled for transfemoral peripheral angiography or endovascular intervention with a common femoral artery puncture, 6–8F sheath, successful hemostasis with a 6F ProGlide, ABI >0.9, and normal lower-limb mobility are ideal candidates.

Probably not a fit

Patients with femoral artery diameter <5 mm, prior vascular complications at the puncture site, abnormal cardiopulmonary function, intraoperative platelet count <80×10⁹/L or thrombolytic use, cognitive impairment, or limited lower-limb mobility are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients undergoing transfemoral peripheral angiography or endovascular intervention who achieve hemostasis with a 6F ProGlide device will be enrolled and assigned to predefined ambulation times after the procedure. The study will monitor vascular complications, hematoma, bleeding, limb ischemia, time to ambulation, and patient comfort. Key eligibility includes common femoral artery puncture, use of 6–8F sheaths, and preoperative ABI >0.9, while those with small femoral vessels, prior puncture-site complications, significant cardiopulmonary disease, or coagulopathy are excluded. The aim is to identify an ambulation schedule that balances patient safety with shorter bed rest and greater efficiency.

Why it matters

Potential benefit: If successful, the findings could allow patients to get up sooner after ProGlide closure, reducing bed rest, discomfort, and length of stay without increasing vascular complications.

How similar studies have gone: Smaller reports, including work by Sekhar et al., have shown early ambulation is feasible after ProGlide closure in coronary procedures, but evidence specific to transfemoral peripheral interventions is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Scheduled for peripheral angiography or endovascular intervention via transfemoral access.
* Femoral artery puncture site located at the common femoral artery.
* Use of 6-8F vascular sheath.
* Hemostasis achieved with 6F ProGlide closure device (defined as no active bleeding, no hematoma formation, and no ischemia of the punctured limb after closure).
* Preoperative ankle-brachial index (ABI) \> 0.9 on both sides.
* Conscious, cooperative, and with normal lower limb mobility.

Exclusion Criteria:

* Undergoing carotid artery intervention.
* Femoral artery diameter \< 5 mm, or effective lumen \< 5 mm due to plaque burden.
* History of vascular complications at the puncture site.
* Abnormal cardiopulmonary function.
* Intraoperative platelet count \< 80 × 10⁹/L, or use of thrombolytic agents.
* Cognitive impairment, uncooperative, or limited lower limb mobility.

Where it's running

  • Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Hui Dong, MD — Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
  • Study coordinator: Hui Dong, MD
  • Email: donghui666@sina.com
  • Phone: 86-010-88322385

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Single-needle distal return for long-term AV fistula care

    This trial tests a single-needle method that draws blood from your arm fistula and returns it through a foot or lower-leg vein to see if it reduces damage and the need for repeat procedures in adults on thrice-weekly hemodialysis.

    Recruiting Suzhou Municipal Hospital of Anhui Province · Suzhou, Anhui · NCT07372027

  • New device to improve intravenous therapy safety

    This study is testing a new device that aims to make intravenous treatments safer and more effective for patients by reducing risks like infections and catheter problems.

    Recruiting Fundacion Miguel Servet · Pamplona, Navarre · NCT06938750

  • Comparing three types of arteriovenous fistulas for dialysis access

    This study is trying to find out which of three types of arteriovenous fistulas works best for people on dialysis to help them get the best access for their treatment.

    Recruiting Wroclaw Medical University · Wroclaw · NCT06550479

  • SelfWrap-Assisted Arteriovenous Fistulas for Chronic Kidney Disease

    This study is testing if a new wrap called SelfWrap can make it safer and more effective for people with chronic kidney disease to have a new arteriovenous fistula created.

    Recruiting at 28 sites VenoStent · Bullhead City, Arizona and 27 other locations · NCT06001827

  • Device for easier access to dialysis through arteriovenous fistulas

    This study is testing a new device called VenaSure to see if it can make it easier and safer for people on hemodialysis to access their arteriovenous fistulas.

    Recruiting at 8 sites Voyager Biomedical · Dothan, Alabama and 7 other locations · NCT05490225

  • Comparing radial and femoral access methods for cardiac catheterization

    This study is testing whether using the wrist or the groin for heart catheterization is better for patients in terms of satisfaction and complications.

    Recruiting at 5 sites Minneapolis Heart Institute Foundation · San Francisco, California and 5 other locations · NCT04077762

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.